Industry Supported Symposia sessions will be offered to Conference attendees free of charge. These will be sponsored by a variety of Pharmaceutical and Biomarker Companies as well as non-profit organizations. You are encouraged to attend these symposia as the topics have been chosen after consultation with the Scientific Committee and will compliment the Plenary Sessions, Education and Mini Symposia of the Conference.
Please click on the Session titles to get further session information.
| Sunday, 3 July 2011 | |
| 11:00 - 13:00 | Johns Hopkins University Symposium supported by an educational grant from Eli Lilly: Histology Matters: Personalized Therapy for Patients with NSCLC |
| 16:00 - 18:00 | Symposium supported by AstraZeneca: EGFR Mutation-Positive Advanced NSCLC: Optimising Treatment Sequences Based on Molecular Biology |
| Monday, 4 July 2011 | |
| 07:00 - 08:00 | Symposium supported by Varian Medical Systems: Expanding Options For High Risk Operable Early-Stage NSCLC Patients |
IMER Symposium supported by an educational grant from Genentech and Bristol-Myers Squibb Company: The Emerging and Evolving Role of Personalized Therapy in Non-Small Cell Lung Cancer (NSCLC) |
|
| 12:15 - 14:15 | Professional Education Services Group Symposium supported by an educational grant from Eli Lilly: The Evolution From Empiric to Personalized Treatment The Interrelationship of Histology, Biomarkers, and Maintenance Therapy |
| 18:30 - 20:00 | Personalized Medicine in NSCLC: Myth or Reality? CMI Education Institute Satellite supported by Merck Serono |
| Tuesday, 5 July 2011 | |
07:00 - 08:00
|
Symposium supported by Response Genetics: Biomarker-Driven Prospective Clinical Trial: Clinical Use of Tumor Molecular Determinants to Enhance Patient Benefit |
| Symposium supported by Daiichi Sankyo: c-MET - An Important New Target for Lung Cancer Therapy | |
| Wednesday, 6 July 2011 | |
| 12:15 - 14:15 | prIME Oncology Symposium supported by Roche: Practical Approaches to Non Small Cell Lung Cancer Management in the Era of Personalized Therapy |
| 18:00 - 20:00 | Symposium supported by Boehringer Ingelheim: Maintaining Momentum in NSCLC Research |
Thank you for attending the 14th World Conference on Lung Cancer. We hope to see you again at the 15th World Conference on Lung Cancer 2013 in Sydney, Australia. - MARK YOUR CALENDAR TO ATTEND -
|
|
